Noninvasive prenatal genetic testing (NIPT) is an advance in the detection of fetal
chromosomal aneuploidies that analyzes cell-free fetal DNA in the blood of a pregnant …

Noninvasive prenatal testing (NIPT) has had a profound influence in the field of prenatal
diagnosis since the 1997 discovery of cell‐free fetal DNA in maternal blood. Research has …

Objective The aim of this study was to investigate how the introduction of noninvasive
prenatal testing (NIPT) impacted women's testing choices following a positive prenatal …

Objective To investigate the benefits and costs of implementing non-invasive prenatal
testing (NIPT) for Down's syndrome into the NHS maternity care pathway. Design …

Objective The goals of this study were to assess global trends in clinical implementation of
noninvasive prenatal testing (NIPT), as commercial tests are marketed increasingly …

Non-invasive prenatal testing (NIPT) and its potential to test for multiple disorders has
received much attention. This study explores attitudes of women and men towards NIPT, and …

Background: The introduction of non-invasive prenatal testing (NIPT) for Down's syndrome
into routine state-funded antenatal care in the UK is approaching. Methods: We conducted …

The identification of cell-free fetal DNA (cffDNA) in maternal plasma in 1997 heralded the
most significant change in obstetric care for decades, with the advent of safer screening and …

Purpose: To compare the preferences of women and health professionals for key attributes
of noninvasive prenatal diagnosis for Down syndrome relative to current invasive tests …

Non-invasive prenatal testing was first discovered in 1988; it was primarily thought to be
able to detect common aneuploidies, such as Patau syndrome (T13), Edward Syndrome …